Seattle-area health data company Truveta announced $320 million in fresh funding and an ambitious new initiative to create a giant genomic dataset. The new investment — which comes from 17 health systems, Illumina, and Regeneron — pushes Truveta’s valuation above $1 billion, making it the latest unicorn to emerge from the Seattle region.
Founded in 2020, Truveta aims to aggregate medical records data from 30 partner institutions to link treatments with outcomes and underlying health. Its platform has 120 million de-identified patient medical records updated daily.